Ezricare Artificial Tears

Ezricare Artificial Tears Lawsuit

The producer of a brand of over-the-counter eye drops is recalling the product after a possible link to an outbreak of drug-resistant infections, according to U.S. health officials.

Both the Food and Drug Administration and the Centers for Disease Control and Prevention are advising against the use of EzriCare Artificial Tears, as they may be contaminated and linked to an outbreak of Pseudomonas aeruginosa, causing a series of serious bacterial infections, vision damage and even death.

The maker of the product, Global Pharma, issued a voluntary nationwide recall. The product was additionally linked to hospitalization and blindness. Pseudomonas are a type of bacteria commonly found in soil or water, while Pseudomonas aeruginosa can be responsible for the infection of the lungs, blood and other parts of the body in humans, particularly post-surgery, according to the CDC.

Opened bottles of EzriCare artificial tears matched the outbreak strain. The CDC is currently testing unopened bottles of the product to see if the bottles became contaminated during manufacturing. It is recommending that clinics and patients pause their use of the product until both the CDC and FDA issue additional guidance.

FDA warns consumers not to purchase or use EzriCare Artificial Tears due to potential contamination.

Individuals who suffered vision loss or other serious health consequences from a bacterial infection related to artificial tear drops could be entitled to significant financial compensation. Those who have used the product may begin showing symptoms of an eye infection, which include yellow, green, or clear discharge from the eye, eye pain or discomfort, redness of the eye or eyelid or blurry vision